Market Tracker

08/26 5:16pm ET

Edwards Lifesciences Corp (NYSE:EW)

115.26
Delayed Data
As of Aug 26
 +0.49 / +0.43%
Today’s Change
66.57
Today|||52-Week Range
118.92
+45.94%
Year-to-Date
'Mad Money' Lightning Round: Buy Edwards Lifesciences, Five Below
Aug 25 / TheStreet.com - Paid Partner Content
Stock Market News for August 19, 2016
Aug 19 / Zacks.com - Paid Partner Content
Edwards Lifesciences: Rallies on Strong THV Sales, View Up
Aug 22 / Zacks.com - Paid Partner Content
FDA OKs Edwards Lifesciences' Sapien 3 for Extended Use
Aug 19 / Zacks.com - Paid Partner Content
Why Edwards Lifesciences Could Be About to Soar
Aug 20 / MotleyFool.com - Paid Partner Content
FDA Approves Edwards Lifesciences' Intuity Elite Heart Valve
Aug 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close114.77
Today’s open114.87
Day’s range114.41 - 115.86
Volume978,114
Average volume (3 months)1,575,454
Market cap$24.5B
Dividend yield--
Data as of 4:02pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-39.84%
Earnings growth (this year)+25.77%
Earnings growth (next 5 years)+17.50%
Revenue growth (last year)+7.35%
P/E ratio47.6
Price/Sales6.98
Price/Book9.92

Competitors

 Today’s
change
Today’s
% change
ISRGIntuitive Surgical-1.16-0.17%
SNNSmith & Nephew PLC+0.25+0.76%
SYKStryker Corp+1.13+1.00%
STESTERIS plc+0.54+0.78%
Data as of 4:02pm ET, 08/26/2016

Financials

Next reporting dateOctober 24, 2016
EPS forecast (this quarter)$0.67
Annual revenue (last year)$2.5B
Annual profit (last year)$494.9M
Net profit margin19.85%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Michael A. Mussallem
Chief Financial Officer &
Vice President
Scott B. Ullem
Corporate headquarters
Irvine, California

Forecasts